Skip to main content

LL713 (Ofloxacin 400 mg)

Pill with imprint LL713 is White, Capsule-shape and has been identified as Ofloxacin 400 mg. It is supplied by Larken Laboratories Inc.

Ofloxacin is used in the treatment of bladder infection; anthrax; anthrax prophylaxis; bone infection; nongonococcal urethritis and belongs to the drug class quinolones. Risk cannot be ruled out during pregnancy. Ofloxacin 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LL713

Ofloxacin

Imprint
LL713
Strength
400 mg
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Quinolones
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Larken Laboratories Inc
National Drug Code (NDC)
68047-0713
Inactive Ingredients
lactose anhydrous, corn starch, hydroxypropyl cellulose, hypromellose 2208 (3 mPa.s), hypromellose 2910 (6 mPa.s), magnesium stearate, polyethylene glycol 400, polysorbate 80, sodium starch glycolate type A potato, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.